Natural Products and Bioprospecting    2011, Vol. 1 Issue (2) : 62-70     DOI: 10.1007/s13659-011-0029-1
Review |
Self-medication with nutritional supplements and herbal over-thecounter products
Tolga EICHHORNa, Henry Johannes GRETENb, Thomas EFFERTHa
a Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany;
b Heidelberg School of Chinese Medicine, Karlsruher Straße 12, 69126 Heidelberg, Germany, and Biomedical Sciences Institute Abel Salazar, University of Porto, Portugal
Download: PDF(464 KB)   HTML ()  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  In recent years, the popularity increased for nutritional supplements and herbal products. Prescription drugs, but not herbal therapies are paid by health insurances. They are sold over-the-counter(OTC) on the patients' own expense. However, there are potential risks of self-medication, e. g. incorrect self-diagnosis, severe adverse reactions, dangerous drug interactions, risk of addiction etc. They are often used by patients at their own discretion without knowledge of and control by their physicians. Certain users are at risk of intoxication. Multiple medications taken by older patients increase the risk for adverse drug reactions, drug-drug interactions, and compliance problems for this age group(polypharmacy). Herbals should be discontinued prior to operations to avoid interactions with anesthetics or anticoagulants. Herbal preparations may also be carcinogenic or interfere with cancer treatments. Pregnant women use various OTC preparations. However, in many cases, it is unclear whether their use is safe for mother or baby. Self-medication with herbals is also largely distributed among anxious and depressive patients, and patients with other conditions and symptoms. The popularity of herbal products has also brought concerns on quality, efficacy and safety. Cases of botanical misidentification, contaminations with heavy metals, pesticides, radioactivity, organic solvents, microbials as well as adulteration with chemical drugs necessitate the establishment of international quality control standards. Hepatotoxic effects have been reported for more than 300 plant species, and some commonly used herbs have been demonstrated to interact with Western medication. Health care professionals have a critical responsibility assessing the self-care ability of their patients. Databases are available for pharmacists with information on action, side effects and toxicities as well as herb-drug interactions. There is a need for established guidelines regarding the correct use of nutritional supplements and herbal OTC preparations(phytovigilance). Physicians, pharmacists, and other health care professionals have to counsel patients and the general public on the benefits and risks associated with herbal drugs. Information centers for consumers and general practitioners are needed, and convincing evidence on safety and efficacy of herbal products has to be demonstrated in placebo-controlled, double blind and randomized clinical trials.
Keywords botanicals      contamination      complementary and alternative medicine      drug interactions      geriatric      gynecology      insomnia      hepatotoxicity      menopause      nephrotoxicity      over-the-counter      pain      phase I/II enzymes      pharmacognosy      pharmacovigilance      phytochemicals      phytotherapy      phytovigilance      quality control     
Issue Date: 24 November 2017
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Tolga EICHHORN
Henry Johannes GRETEN
Thomas EFFERTH
Trendmd:   
Cite this article:   
Tolga EICHHORN,Henry Johannes GRETEN,Thomas EFFERTH. Self-medication with nutritional supplements and herbal over-thecounter products[J]. Natural Products and Bioprospecting, 2011, 1(2): 62-70.
URL:  
http://npb.kib.ac.cn/EN/10.1007/s13659-011-0029-1     OR     http://npb.kib.ac.cn/EN/Y2011/V1/I2/62
[1] Barrett, B.; Kiefer, D.; Rabago, D. Altern. Ther. Health Med. 1999, 5, 40-49.
[2] Akerele, O. World Health Forum 1993, 14, 390-95.
[3] Chan, K. Chemosphere 2003, 52, 1361-1371.
[4] Maxion-Bergemann, S.; Wolf, M.; Bornhoft, G.; Matthiessen, P. F.; Wolf, U. Forsch Komplementmed. 2006, 13, 42-45.
[5] Ruiz, M. E. Curr. Drug Saf. 2010, 5, 315-323.
[6] Consolini, A. E.; Ragone, M. I. Curr. Drug Saf. 2010, 5, 333-341.
[7] Yusuff, K. B.; Tayo, F. Int. J. Clin. Pharm. 2011, 33, 558-564.
[8] Cassileth, B. R. CA Cancer J. Clin. 1999, 49, 362-375.
[9] Glisson, J. K.; Walker, L. A. Am. J. Med. 2010, 123, 577-582.
[10] Vora, C. K.; Mansoor, G. A. Curr. Hypertens. Rep. 2005, 7, 275-280.
[11] Bent, S.; Ko, R. Am. J. Med. 2004, 116, 478-485.
[12] Huxtable, R. J. Drug Saf. 1990, 5, 126-136.
[13] Vacas Rodilla, E.; Castellà Dagà, I.; Sanchez Giralt. M.; Pujol Algué, A.; Pallarés Comalada, M. C.; Balagué Corbera, M. Aten. Primaria. 2009, 41, 269-274.
[14] Tam-McDevitt, J. Oncology (Williston Park). 2008, 22, 1052-1060.
[15] Gonzalez-Stuart, A. Maturitas 2011, 68, 52-55.
[16] Fitzcharles, M. A.; Lussier, D.; Shir, Y. Drugs Aging 2010, 27, 471-490.
[17] Fitzpatrick, A. L.; Fried, L. P.; Williamson, J.; Crowley, P.; Posey, D.; Kwong, L.; Bonk, J.; Moyer, R.; Chabot, J.; Kidoguchi, L.; Furberg, C. D.; DeKosky, S. T. Contemp. Clin. Trials 2006, 27, 541-553.
[18] Mahady, G. B. J. Cardiovasc. Nurs. 2002, 16, 21-32.
[19] Frost, E. A. Middle East J. Anesthesiol. 2006, 18, 851-878.
[20] King, A. R.; Russett, F. S.; Generali, J. A.; Grauer, D. W. BMC Complement. Altern. Med. 2009, 9, 38.
[21] Norred, C. L.; Zamudio, S.; Palmer, S. K. AANA J. 2000, 68, 13-18.
[22] Rowe, D. J.; Baker, A. C. Aesthet. Surg. J. 2009, 29, 150-157.
[23] Spolarich, A. E.; Andrews, L. J. Dent. Hyg. 2007, 81, 67.
[24] (a) Montbriand, M. J. Oncol. Nurs. Forum 2004, 31, E99-115; (b) Montbriand, M. J. Erratum in:Oncol. Nurs. Forum 2006, 33, 684; (c) Montbriand, M. J. Comment in:Oncol. Nurs. Forum 2006, 33, 684; author reply 684.
[25] Gratus, C.; Wilson, S.; Greenfield, S. M.; Damery, S. L.; Warmington, S. A.; Grieve, R.; Steven, N. M.; Routledge, P. BMC Complement. Altern. Med. 2009, 9, 14.
[26] Marks, L. S.; DiPaola, R. S.; Nelson, P.; Chen, S.; Heber, D.; Belldegrun, A. S.; Lowe, F. C.; Fan, J.; Leaders, F. E. Jr.; Pantuck, A. J.; Tyler, V. E. Urology 2002, 60, 369-375; discussion 376-377.
[27] Wong, C. Prostate cancer herbal remedy taken off market. http://altmedicine.about.com/cs/govtregulation/a/PCSpes.htm.
[28] Lowe, F. C. Urology 2001, 58, 71-76; discussion 76-77.
[29] McKenna, L.; McIntyre, M. J. Adv. Nurs. 2006, 56, 636-645.
[30] Born, D.; Barron, M. L. MCN Am. J. Matern. Child Nurs. 2005, 30, 201-206.
[31] Tiran, D. Complement. Ther. Nurs. Midwifery 2002, 8, 191-196.
[32] Holst, L.; Wright, D.; Haavik, S.; Nordeng, H. Midwifery 2011, 27, 80-86.
[33] Dugoua, J. J.; Perri, D.; Seely, D.; Mills, E.; Koren, G. Can. J. Clin. Pharmacol. 2008, 15, e66-73.
[34] Candlish, J. K. Singapore Med. J. 1999, 40, 550-552.
[35] (a) Bray, G. A. Obesity (Silver Spring) 2008, 16, 509-514; (b) Bray, G. A. Erratum in:Obesity (Silver Spring) 2008, 16, 1723.
[36] Saper, R. B.; Eisenberg, D. M.; Phillips, R. S. Am. Fam. Physician 2004, 70, 1731-1738.
[37] (a) Zhu, X.; Proctor, M.; Bensoussan, A.; Smith, C. A.; Wu, E. Cochrane Database Syst. Rev. 2007, 4, CD005288; (b) Zhu, X.; Proctor, M.; Bensoussan, A.; Smith, C. A.; Wu, E. Update in:Cochrane Database Syst. Rev. 2008, 2, CD005288.
[38] Kelley, K. W.; Carroll, D. G. J. Am. Pharm. Assoc. 2003, 50, e106-115.
[39] Haimov-Kochman, R.; Brzezinski, A.; Hochner-Celnikier, D. Eur. J. Contracept. Reprod. Health Care 2008, 13, 133-137.
[40] Saeed, S. A.; Bloch, R. M.; Antonacci, D. J. Am. Fam. Physician 2007, 76, 549-556.
[41] Singh, Y. N.; Singh, N. N. CNS Drugs 2002, 16, 731-743.
[42] Sarris, J.; LaPorte, E.; Schweitzer, I. Aust. N. Z. J. Psychiatry 2011, 45, 27-35.
[43] Morin, A. K.; Jarvis, C. I.; Lynch, A. M. Pharmacotherapy 2007, 27, 89-110.
[44] Meolie, A. L.; Rosen, C.; Kristo, D.; Kohrman, M.; Gooneratne, N.; Aguillard, R. N.; Fayle, R.; Troell, R.; Townsend, D.; Claman, D.; Hoban, T.; Mahowald, M. J. Clin. Sleep Med. 2005, 1, 173-187.
[45] Steele, T.; Rogers, C. J.; Jacob, S. E. Dermatol. Nurs. 2007, 19, 448-450, 457-463.
[46] Reuter, J.; Merfort, I.; Schempp, C. M. Am. J. Clin. Dermatol. 2010, 11, 247-267.
[47] Burgess, J. A.; van der Ven, P. F.; Martin, M.; Sherman, J.; Haley, J. J. Contemp. Dent. Pract. 2008, 9, 88-98.
[48] Kassler, W. J.; Blanc, P.; Greenblatt, R. Arch. Intern. Med. 1991, 151, 2281-2288.
[49] Roxas, M.; Jurenka, J. Altern. Med. Rev. 2007, 12, 25-48.
[50] Silber, T. J. J. Adolesc. Health 2005, 37, 256-260.
[51] Manoguerra, A. S.; Cobaugh, D. J. Clin. Toxicol. (Phila) 2005, 43, 1-10.
[52] Chan, K. Chemosphere 2003, 52, 1361-1371.
[53] Efferth, T.; Kaina, B. Curr. Drug Metabol. 2012, in press.
[54] Efferth, T. Chin. J. Nat. Med. 2011, 9, 1-6.
[55] Larrey, D. Presse Med. 1994, 23, 691-693.
[56] Stickel, F.; Egerer, G.; Seitz, H. K. Public Health Nutr. 2000, 3, 113-124.
[57] Bent, S. J. Gen. Intern. Med. 2008, 23, 854-859.
[58] Ulbricht, C.; Chao, W.; Costa, D.; Rusie-Seamon, E.; Weissner, W.; Woods, J. Curr. Drug Metab. 2008, 9, 1063-1120.
[59] Delgoda, R.; Westlake, A. C. Toxicol Rev. 2004, 23, 239-249.
[60] Shord, S. S.; Shah, K.; Lukose, A. Integr. Cancer Ther. 2009, 8, 208-227.
[61] Dykeman-Sharpe, J. CANNT J. 2003, 13, 17-28.
[62] Blowey, D. L. Adolesc. Med. Clin. 2005, 16, 31-43.
[63] Cheng, K. F.; Leung, K. S.; Leung, P. C. Am. J. Chin. Med. 2003, 31, 163-169.
[64] Ioannides, C. Xenobiotica 2002, 32, 451-478.
[65] Kober, M.; Pohl, K.; Efferth, T. Curr. Drug Metab. 2008, 9, 1027-1037.
[66] Yoon, S. L.; Schaffer, S. D. Geriatr. Nurs. 2006, 27, 118-129.
[67] Bush, T. M.; Rayburn, K. S.; Holloway, S. W.; SanchezYamamoto, D. S.; Allen, B. L.; Lam, T.; So, B. K.; Tran, de H.; Greyber, E. R.; Kantor, S.; Roth, L. W. Altern. Ther. Health Med. 2007, 13, 30-35.
[68] Brazier, N. C.; Levine, M. A. Am. J. Ther. 2003, 10, 163-169.
[69] Mohamed, M. E.; Frye, R. F. Planta Med. 2011, 77, 311-321.
[70] Laven, A. Pharm. Unserer Zeit 2009, 38, 448-453.
[71] Glisson, J. K.; Walker, L. A. Am. J. Med. 2010, 123, 577-582.
[72] Tiran, D. Br. J. Nurs. 2006, 15, 645-648.
[73] Mitty, E.; Flores, S. Geriatr. Nurs. 2007, 28, 83-89.
[74] Jaski, M. E.; Schwartzberg, J. G.; Guttman, R. A.; Noorani, M. Eff. Clin. Pract. 2000, 3, 31-34.
[75] McCabe, B. J. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7, 21-26.
[76] Howard, N.; Tsourounis, C.; Kapusnik-Uner, J. J. Altern. Complement. Med. 2001, 7, 667-680.
[77] Newton, G. D.; Benninghoff, A. J.; Pray, W. S.; Popovich, N. G. J. Am. Pharm. Assoc. (Wash) 2002, 42, 267-277.
[78] Lim, J. M.; Sullivan, E.; Kennedy, D. Aust. N. Z. J. Obstet. Gynaecol. 2009, 49, 168-172.
[79] Assemi, M.; Torres, N. M.; Tsourounis, C.; Kroon, L. A.; McCart, G. M. Ann. Pharmacother. 2002, 36, 787-792.
[1] Steffen WÖLL, Sun Hee KIM, Henry Johannes GRETEN, Thomas EFFERTH. Animal plant warfare and secondary metabolite evolution[J]. Natural Products and Bioprospecting, 2013, 3(1): 1-7.
[2] Yanis CARO, Linda ANAMALE, Mireille FOUILLAUD, Philippe LAURENT, Thomas PETIT, Laurent DUFOSSEa. Natural hydroxyanthraquinoid pigments as potent food grade colorants: an overview[J]. Natural Products and Bioprospecting, 2012, 2(5): 174-193.
[3] Hassan KHALID, Wail Elsadig ABDALLA, Haider ABDELGADIR, Till OPATZ, Thomas EFFERTH. Gems from traditional north-African medicine: medicinal and aromatic plants from Sudan[J]. Natural Products and Bioprospecting, 2012, 2(3): 92-103.
[4] Yan-Ming WANG, Min XU, Dong WANG, Hong-Tao ZHU, Chong-Ren YANG, Ying-Jun ZHANG. Review on “Long-Dan”, one of the traditional Chinese medicinal herbs recorded in Chinese Pharmacopoeia[J]. Natural Products and Bioprospecting, 2012, 2(1): 1-10.
[5] Katharina DEEG, Tolga EICHHORN, Gladys ALEXIE, Nadine KRETSCHMER, Kai ANDERSCH, Rudolf BAUER, Thomas EFFERTH. Growth inhibition of human acute lymphoblastic CCRF-CEM leukemia cells by medicinal plants of the West-Canadian Gwich' in Native Americans[J]. Natural Products and Bioprospecting, 2012, 2(1): 35-40.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
  • Add:132# Lanhei Road, Heilongtan, Kunming 650201, Yunnan, China
  • Fax:+86 871 65223223
  • Tel:+86 871 65223223
  • E-mail: npb@mail.kib.ac.cn
  • 0

Copyright © 2017 Natural Products and Bioprospecting, All Rights Reserved.